Literature DB >> 19531902

Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization.

Yutaka Furukawa1, Natsuhiko Ehara, Ryoji Taniguchi, Yoshisumi Haruna, Neiko Ozasa, Naritatsu Saito, Takahiro Doi, Kozo Hoshino, Toshihiro Tamura, Satoshi Shizuta, Mitsuru Abe, Masanao Toma, Takeshi Morimoto, Satoshi Teramukai, Masanori Fukushima, Toru Kita, Takeshi Kimura.   

Abstract

BACKGROUND: The prevalence of coronary artery disease (CAD) is increasing in young adults. Risk factor profiling will help to prevent heart attacks in young patients. This study aimed to analyze the risk factor profile and predictors of major cardiovascular events (MACE) in young CAD patients. METHODS AND
RESULTS: From the Coronary REvascularization Demonstrating Outcome study in the Kyoto (CREDO-Kyoto) registry of Japanese patients undergoing their first coronary revascularization, 6,320 patients with complete data for all variables for statistical analyses were divided into younger (< or =55 years; n=898; 14.3%) and older (>55 years; n=5,422; 85.7%) patients. The risk factors that were more prevalent in the younger patients than in the older patients included: male sex, body mass index of >25 kg/m(2), current smoker, family history of CAD, dyslipidemia and metabolic syndrome-like risk factor accumulation. Multivariate analyses revealed that chronic kidney disease (CKD) was the only significant predictor of MACE, the composite of cardiovascular death, myocardial infarction and cerebrovascular accident, in the younger patients. Importance of CKD as a prognostic factor was consistently shown by a multivariate analysis in the older patients.
CONCLUSIONS: Accumulation of multiple risk factors is prevalent and CKD is associated with MACE in young Japanese CAD patients.

Entities:  

Mesh:

Year:  2009        PMID: 19531902     DOI: 10.1253/circj.cj-08-1083

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Can family history of premature coronary artery disease be a risk factor for clinical outcomes in patients with acute myocardial infarction?

Authors:  Ju Han Kim; Myung Ho Jeong
Journal:  Korean J Intern Med       Date:  2013-08-14       Impact factor: 2.884

3.  Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction.

Authors:  David D McManus; Stephen M Piacentine; Darleen Lessard; Joel M Gore; Jorge Yarzebski; Frederick A Spencer; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2011-05-31       Impact factor: 2.778

4.  Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry.

Authors:  Choongki Kim; Hyuk-Jae Chang; Iksung Cho; Ji Min Sung; Donghoon Choi; Myung Ho Jeong; Yang Soo Jang
Journal:  Korean J Intern Med       Date:  2013-08-14       Impact factor: 2.884

5.  Assessment of Cardiovascular Risk Factors Among University Students: The Gender Factor.

Authors:  Mohammad Y Gharaibeh; Karem H Alzoubi; Omar F Khabour; Lubna Tinawi; Rawan Hamad; Esraa F Keewan; Sulaiman K Matarneh; Mahmoud A Alomari
Journal:  Cardiol Res       Date:  2012-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.